Get our Free Patent Expiration, Litigation, and Drug Price Updates

Serving hundreds of leading biopharmaceutical companies globally:

Cipla
Accenture
Farmers Insurance
Fuji
Baxter
UBS

Generated: April 22, 2019

DrugPatentWatch Database Preview

Drug Price Trends for SUCRALFATE

« Back to Dashboard

Drug Price Trends for SUCRALFATE

Average Pharmacy Cost for SUCRALFATE

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug Name NDC Price/Unit ($) Unit Date
SUCRALFATE 1 GM TABLET 00093-2210-01 0.21751 EACH 2019-02-20
SUCRALFATE 1 GM TABLET 00093-2210-98 0.21751 EACH 2019-02-20
SUCRALFATE 1 GM TABLET 00591-0780-01 0.21751 EACH 2019-02-20
SUCRALFATE 1 GM TABLET 00093-2210-05 0.21751 EACH 2019-02-20
Drug Name NDC Price/Unit ($) Unit Date

Subscribe to access the full database, or try a Free Trial

Best Wholesale Price for SUCRALFATE

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available to any customer under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Unit Dates Price Type
CARAFATE 1GM TAB Allergan USA, Inc 58914-0171-10 100 349.45 3.49450 EACH 2018-09-30 - 2023-09-29 FSS
CARAFATE 1GM TAB Allergan USA, Inc 58914-0171-10 100 253.95 2019-01-01 - 2023-09-29 Big4
CARAFATE 1GM TAB Allergan USA, Inc 58914-0171-10 100 349.45 2019-01-01 - 2023-09-29 FSS
CARAFATE 500MG/5ML ORAL SUSP Allergan USA, Inc 58914-0170-14 414ML 52.53 0.12688 ML 2018-09-30 - 2023-09-29 Big4
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Unit Dates Price Type

Subscribe to access the full database, or try a Free Trial

Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Citi
Express Scripts
McKesson
Chinese Patent Office
Baxter
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.